Antibiotic Eye Drops Are NOT Indicated Post-Cataract Surgery
Topical antibiotic eye drops should not be routinely used after uncomplicated cataract surgery when intracameral antibiotics are administered intraoperatively. The most recent evidence demonstrates no additional benefit in preventing endophthalmitis when topical antibiotics are added to intracameral prophylaxis.
The Evidence-Based Rationale
The 2022 American Academy of Ophthalmology Preferred Practice Pattern explicitly states: "There is substantial evidence that intracameral antibiotic administration reduces the risk of postoperative bacterial endophthalmitis. Increasing evidence also suggests that topically applied antibiotics do not add to the benefit of intracameral injection" 1.
This guideline recommendation is strongly supported by the most recent and highest-quality research:
Key Supporting Data
A 2025 meta-analysis of over 1.2 million eyes found no statistically significant difference in endophthalmitis rates between patients receiving intracameral antibiotics alone versus those receiving intracameral plus topical antibiotics (p = 0.97), with identical incidence rates of 0.0004 in both groups 2. This represents the largest and most recent systematic evaluation of this question.
Additional 2026 evidence reinforces this finding, concluding that "postoperative topical antibiotics are not indicated when intracameral prophylaxis is applied" in uncomplicated cases 3.
When to Consider Topical Antibiotics
Reserve topical antibiotic drops ONLY for high-risk situations:
- Complicated surgery (posterior capsular rupture, vitreous loss)
- Immunocompromised patients
- Chronic blepharitis or active ocular surface disease
- Inability to administer intracameral antibiotics intraoperatively
Important Clinical Considerations
Avoiding topical antibiotics in routine cases provides multiple benefits:
- Reduces antibiotic resistance: Unnecessary topical antibiotic use contributes to antimicrobial resistance development 2, 5
- Improves patient compliance burden: Eliminates the challenge of drop administration and adherence issues 4
- Cost-effectiveness: Intracameral antibiotics alone are more cost-effective than combination regimens 5
- Reduces medical waste: Supports sustainable healthcare practices 4
Common Pitfall to Avoid
Do not confuse the lack of benefit of topical antibiotics with the critical importance of intracameral antibiotics. Intracameral antibiotic administration (typically moxifloxacin 500 μg or cefuroxime 1 mg) at the end of surgery is essential and reduces endophthalmitis risk 3.5 to 4.9-fold 1, 5. The question is whether adding topical drops provides additional benefit—which it does not.
The Shift in Practice
A 2018 study demonstrated that when intracameral cefuroxime prophylaxis is performed, "the benefit of the application of topical antibiotics after cataract surgery is questionable" 6. This finding has been consistently replicated in subsequent larger studies, leading to the current guideline recommendations and the emerging "dropless after cataract surgery" (DACS) approach 4.
In summary: Use intracameral antibiotics intraoperatively for all patients, but omit routine postoperative topical antibiotic drops in uncomplicated cases. This approach optimizes patient outcomes while minimizing antibiotic resistance and healthcare costs.